Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antinuclear antibodies in progressive systemic sclerosis.

P Riboldi, R Asero, L Origgi

    Clinical and Experimental Rheumatology
    |July 1, 1985
    PubMed
    Summary

    Antinuclear antibodies are common in progressive systemic sclerosis (PSS). Anti-centromere antibodies are linked to CREST syndrome, while anti-Scl 70 antibodies indicate diffuse scleroderma, aiding in subgroup classification.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6<sup>+</sup>B helper T cells in systemic lupus erythematosus.

    Proceedings of the National Academy of Sciences of the United States of America·2020
    Same author

    Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.

    BioMed research international·2018
    Same author

    Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

    BJOG : an international journal of obstetrics and gynaecology·2018
    Same author

    Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?

    Autoimmunity reviews·2017
    Same author

    Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study.

    European annals of allergy and clinical immunology·2017
    Same author

    Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

    Lupus·2016

    Area of Science:

    • Rheumatology
    • Immunology
    • Autoimmunity

    Background:

    • Progressive systemic sclerosis (PSS) is a complex autoimmune disease.
    • Accurate classification of PSS subgroups is crucial for understanding disease progression and treatment.

    Purpose of the Study:

    • To investigate the prevalence and significance of specific antinuclear antibodies (ANAs) in patients with PSS.
    • To determine if ANA specificities can serve as biomarkers for distinct PSS subgroups.

    Main Methods:

    • Sera from 84 PSS patients were analyzed for ANAs using immunofluorescence on HEp2 cells and gel immunodiffusion.
    • Antibody specificities, including anti-centromere, anti-Scl 70, and anti-nRNP, were identified.

    Main Results:

    Related Experiment Videos

  • Ninety-five percent of PSS patients had detectable ANAs.
  • Anti-centromere antibodies showed a strong association with CREST syndrome (93% of CREST patients).
  • Anti-Scl 70 antibodies were found in 60% of diffuse scleroderma patients and were associated with a grainy speckled HEp2 pattern.

    • Conclusions:

    • Anti-centromere and anti-Scl 70 antibodies are valuable serological markers for differentiating between CREST syndrome and diffuse scleroderma.
    • ANA testing can aid in the classification of PSS patients into clinically relevant subgroups.